Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

Shopping cart

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

  1. Home
  2. Technical Content
  3. Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

Maldonado-Pérez, N., Tristán-Manzano, M., Justicia-Lirio, P., Martínez-Planes, E., Muñoz, P., Pavlovic, K., Cortijo-Gutiérrez, M., Blanco-Benítez, C., Castella, M., Juan, M., Wenes, M., Romero, P., Molina-Estévez, F. J., Marañón, C., Herrera, C., Benabdellah, K., & Martin, F. (2022). Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma. Frontiers in immunology, 13, 1011858. https://doi.org/10.3389/fimmu.2022.1011858

CONTACT

QUESTIONS IN YOUR MIND?

Connect With Our Technical Specialist.

KNOW WHAT YOU WANT?

Request For A Quotation

DON'T MISS OUR.
FOLLOW US ON SOCIAL MEDIA!

OTHER BLOGS YOU MIGHT LIKE

HOW CAN WE HELP YOU? Our specialists are to help you find the best product for your application. We will be happy to help you find the right product for the job.

TALK TO A SPECIALIST

Contact our Customer Care, Sales & Scientific Assistance

EMAIL US

Consult and asked questions about our products & services

DOCUMENTATION

Documentation of Technical & Safety Data Sheet, Guides and more..